Connection

Alessandra Vultaggio to Omalizumab

This is a "connection" page, showing publications Alessandra Vultaggio has written about Omalizumab.
Connection Strength

0.773
  1. The percentage of patients achieving complete remission of urticaria increases with repeated courses of treatment. J Allergy Clin Immunol Pract. 2019 Jan; 7(1):339-340.
    View in: PubMed
    Score: 0.616
  2. Omalizumab dampens type 2 inflammation in a group of long-term treated asthma patients and detaches IgE from FceRI. Eur J Immunol. 2018 12; 48(12):2005-2014.
    View in: PubMed
    Score: 0.157
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.